Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
Clinical Chemistry|June 14, 2015
Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting StateKhendi T White, M V Moorthy, Akintunde O Akinkuolie, et al.
Scientific Data|July 5, 2020
Probabilistic identification of saccharide moieties in biomolecules and their protein complexesHesam Dashti, William M Westler, Jonathan R Wedell, et al.
JAMA Network Open|January 16, 2019
Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean DietShafqat Ahmad, M Vinayaga Moorthy, Olga V Demler, et al.
Journal of the American Heart Association|December 11, 2017
Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density LipoproteinsPatrick R Lawler, Akintunde O Akinkuolie, Paulo Harada, et al.
Clinical Chemistry|June 28, 2018
Dietary Intakes and Circulating Concentrations of Branched-Chain Amino Acids in Relation to Incident Type 2 Diabetes Risk Among High-Risk Women with a History of Gestational Diabetes MellitusDeirdre K Tobias, Clary Clish, Samia Mora, et al.
Circulation|November 19, 2013
Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)Amit V Khera, Brendan M Everett, Michael P Caulfield, et al.
Clinical Chemistry|November 4, 2017
Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health StudyShafqat Ahmad, Samia Mora, Paul W Franks, et al.
JAMA|September 25, 2003
Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence studySamia Mora, Rita F Redberg, Yadong Cui, et al.
Clinical Chemistry|March 12, 2024
Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in WomenSagar B Dugani, M Vinayaga Moorthy, Olga V Demler, et al.
Diabetes Care|January 17, 2015
Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosisRachel H Mackey, Samia Mora, Alain G Bertoni, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Clinical Chemistry|June 14, 2015
Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting StateKhendi T White, M V Moorthy, Akintunde O Akinkuolie, et al.
Scientific Data|July 5, 2020
Probabilistic identification of saccharide moieties in biomolecules and their protein complexesHesam Dashti, William M Westler, Jonathan R Wedell, et al.
JAMA Network Open|January 16, 2019
Assessment of Risk Factors and Biomarkers Associated With Risk of Cardiovascular Disease Among Women Consuming a Mediterranean DietShafqat Ahmad, M Vinayaga Moorthy, Olga V Demler, et al.
Journal of the American Heart Association|December 11, 2017
Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density LipoproteinsPatrick R Lawler, Akintunde O Akinkuolie, Paulo Harada, et al.
Clinical Chemistry|June 28, 2018
Dietary Intakes and Circulating Concentrations of Branched-Chain Amino Acids in Relation to Incident Type 2 Diabetes Risk Among High-Risk Women with a History of Gestational Diabetes MellitusDeirdre K Tobias, Clary Clish, Samia Mora, et al.
Circulation|November 19, 2013
Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)Amit V Khera, Brendan M Everett, Michael P Caulfield, et al.
Clinical Chemistry|November 4, 2017
Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health StudyShafqat Ahmad, Samia Mora, Paul W Franks, et al.
JAMA|September 25, 2003
Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence studySamia Mora, Rita F Redberg, Yadong Cui, et al.
Clinical Chemistry|March 12, 2024
Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in WomenSagar B Dugani, M Vinayaga Moorthy, Olga V Demler, et al.
Diabetes Care|January 17, 2015
Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosisRachel H Mackey, Samia Mora, Alain G Bertoni, et al.
Pageof 26